Description

N'-(7-[1-(3-Methoxyphenoxy)Ethyl][1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl)-N,n-Dimethyliminoformamide is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active ingredients. This compound is critical for research and development in medicinal chemistry, offering a sophisticated heterocyclic scaffold for targeted drug discovery. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Research: Used in the development of enzyme inhibitors or receptor modulators due to its specific heterocyclic structure.
• Fine Chemical Synthesis: Employed in multi-step organic syntheses requiring a complex, functionalized triazolopyrimidine derivative.
• Agrochemical Research: Potential intermediate for developing new crop protection agents with specific biological activity.

Basic Information

Product Name	N'-(7-[1-(3-Methoxyphenoxy)Ethyl][1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl)-N,n-Dimethyliminoformamide
CAS No.	477865-40-0
Molecular Formula	C19H22N6O3
Molecular Weight	382.42 g/mol
Synonyms	N'-(7-(1-(3-Methoxyphenoxy)ethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-N,N-dimethylformamidine; 477865-40-0; N,N-Dimethyl-N'-[7-[1-(3-methoxyphenoxy)ethyl][1,2,4]triazolo[1,5-a]pyrimidin-2-yl]formamidine; Formamidine, N,N-dimethyl-N'-[7-[1-(3-methoxyphenoxy)ethyl][1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-; BCP31945; CTK8G8068; MolPort-045-635-947
EINECS	Contact for details

Quality Control

Our production of N'-(7-[1-(3-Methoxyphenoxy)Ethyl][1,2,4]Triazolo[1,5-A]Pyrimidin-2-Yl)-N,n-Dimethyliminoformamide adheres to stringent quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the exacting standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (typically 15-25°C). This compound is light-sensitive (store away from light) and may be hygroscopic (moisture-sensitive); therefore, containers should be kept sealed under an inert atmosphere if specified.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.